Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fields

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Seminars in Oncology|May 13, 1998
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancerK K Fields, G J Elfenbein, J B Perkins, et al.
Hematological Oncology|January 1, 1992
Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphomaK K Fields, G J Elfenbein, R A Saleh, et al.
Bone Marrow Transplantation|July 3, 2003
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancerJ D Rizzo, S Williams, J T Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profileK K Fields, G J Elfenbein, H M Lazarus, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonateK M Sekins, J J Coalson, R A deLemos, et al.
Osteoarthritis and Cartilage|June 22, 2026
Deep Learning-based Quantification of Knee Effusion-Synovitis Volume on MRI - Technique Development and ValidationAdrian A Marth, Felix Liu, Ethan Pan, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
British Journal of Haematology|March 1, 1997
Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myelomaO F Ballester, L C Moscinski, K K Fields, et al.
Radiology. Artificial Intelligence|June 12, 2024
The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma MRI DatasetBrandon K K Fields, Evan Calabrese, John Mongan, et al.
Plos One|April 18, 2017
The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitroKawaljit Kaur, Xiaoqing Wu, James K Fields, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Seminars in Oncology|May 13, 1998
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancerK K Fields, G J Elfenbein, J B Perkins, et al.
Hematological Oncology|January 1, 1992
Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphomaK K Fields, G J Elfenbein, R A Saleh, et al.
Bone Marrow Transplantation|July 3, 2003
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancerJ D Rizzo, S Williams, J T Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profileK K Fields, G J Elfenbein, H M Lazarus, et al.
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|January 1, 1994
Long-term partial liquid ventilation (PLV) with perflubron in the near-term baboon neonateK M Sekins, J J Coalson, R A deLemos, et al.
Osteoarthritis and Cartilage|June 22, 2026
Deep Learning-based Quantification of Knee Effusion-Synovitis Volume on MRI - Technique Development and ValidationAdrian A Marth, Felix Liu, Ethan Pan, et al.
JCO Oncology Practice|July 13, 2021
Oncology Medical Home: ASCO and COA StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
British Journal of Haematology|March 1, 1997
Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myelomaO F Ballester, L C Moscinski, K K Fields, et al.
Radiology. Artificial Intelligence|June 12, 2024
The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma MRI DatasetBrandon K K Fields, Evan Calabrese, John Mongan, et al.
Plos One|April 18, 2017
The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitroKawaljit Kaur, Xiaoqing Wu, James K Fields, et al.
Pageof 21